In this, the digital age, where more and more individuals rely heavily on their electronic devices for managing many aspects of day-to-day living, digital apps aimed at improving mental health are becoming increasingly common and have been shown to be effective. This presentation will discuss the efficacy of available and emerging prescription digital therapeutics (PDTs) in treating a variety of mental health concerns including sleep, schizophrenia, ADHD, and substance use disorders as well as practical tips for successfully incorporating PDTs into individualized treatment strategies for patients.
Course Requirements
To receive ACPE credit for this session, you must:
- Register for this course.
- Review the full content of the activity and reflect upon its teachings.
- Complete the evaluation at the end of the activity.
- Provide the necessary details in your profile to ensure correct reporting by AAPP to CPE Monitor.
Faculty Information
View biographical information
Kari Franson, PharmD, PhD, BCPP
Professor of Clinical Pharmacy, USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences; Los Angeles, CA
Learning Objectives
- Identify the features of prescription digital therapeutics and their efficacy in treating various mental health concerns
- Assess the evidence for the utility and effectiveness of prescription digital therapeutics in the management of mental health issues
- Collaborate with patients, families, and the care team to integrate prescription digital therapeutics as part of the treatment plan in order to optimize outcomes for patients with issues affecting their mental health
Continuing Education Credit and Disclosures
AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.